Review article · 2024 · Open access
Frontiers in CAR-T cell therapy for autoimmune diseases
Trends in Pharmacological Sciences, 45(9), 839–857 · Published 14 August 2024 · DOI 10.1016/j.tips.2024.07.005
In brief
“Frontiers in CAR-T cell therapy for autoimmune diseases” is a 2024 review article by Yan-Ruide Li and 4 co-authors, published in Trends in Pharmacological Sciences. OpenAlex counts 103 citations as of 19 November 2026, which puts it in the top 5% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at Trends in Pharmacological Sciences.
- Citations
- 103
- Most cited in
- 2025 (56)
- Field-weighted impact
- 4.88
- References
- 112
- Authors
- 5
Abstract
Chimeric antigen receptor (CAR)-engineered T (CAR-T) cell therapy has demonstrated significant success in treating cancers. The potential of CAR-T cells is now being explored in the context of autoimmune diseases. Recent clinical trials have shown sustained and profound elimination of autoreactive B cells by CAR-T cells, leading to promising autoimmune disease control with minimal safety concerns. These encouraging results have inspired further investigation into CAR-T cell applications for a broader range of autoimmune diseases and the development of advanced cell products with improved efficacy and safety. In this review, we discuss the mechanisms by which CAR-T cells target autoimmune conditions, summarize current preclinical models, and highlight ongoing clinical trials, including CAR-T therapy design, clinical outcomes, and challenges. Additionally, we discuss the limitations and future directions of CAR-T therapy in the treatment of autoimmune diseases.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Li, Y.-R., Lyu, Z., Chen, Y., Fang, Y., & Yang, L. (2024). Frontiers in CAR-T cell therapy for autoimmune diseases. Trends in Pharmacological Sciences, 45(9), 839–857. https://doi.org/10.1016/j.tips.2024.07.005
MLA 9
Li, Yan-Ruide, et al. “Frontiers in CAR-T cell therapy for autoimmune diseases.” Trends in Pharmacological Sciences, vol. 45, no. 9, 2024, pp. 839–857. https://doi.org/10.1016/j.tips.2024.07.005.
Chicago
Li, Yan-Ruide, Zibai Lyu, Yuning Chen, Ying Fang, and Lili Yang. 2024. “Frontiers in CAR-T cell therapy for autoimmune diseases.” Trends in Pharmacological Sciences 45 (9): 839–857. https://doi.org/10.1016/j.tips.2024.07.005.
Harvard
Li, Y.-R. et al. (2024) ‘Frontiers in CAR-T cell therapy for autoimmune diseases’, Trends in Pharmacological Sciences, 45(9), pp. 839–857. doi:10.1016/j.tips.2024.07.005.
IEEE
Y.-R. Li, Z. Lyu, Y. Chen, Y. Fang, and L. Yang, “Frontiers in CAR-T cell therapy for autoimmune diseases,” Trends in Pharmacological Sciences, vol. 45, no. 9, pp. 839–857, 2024, doi: 10.1016/j.tips.2024.07.005.
BibTeX
@article{li2024frontiers,
title = {{Frontiers in CAR-T cell therapy for autoimmune diseases}},
author = {Li, Yan-Ruide and Lyu, Zibai and Chen, Yuning and Fang, Ying and Yang, Lili},
journal = {Trends in Pharmacological Sciences},
year = {2024},
volume = {45},
number = {9},
pages = {839--857},
doi = {10.1016/j.tips.2024.07.005},
url = {https://doi.org/10.1016/j.tips.2024.07.005}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 3 | |
| 2025 | 56 | |
| 2026 | 44 |
Its field-weighted citation impact is 4.88: it has been cited 4.88 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- CAR T-cell therapy
- autoimmune disease
- chimeric antigen receptor
- autoreactive B cells
- B-cell depletion
- preclinical models
- clinical trials
- treatment safety
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Li, Y.-R., Lyu, Z., Chen, Y., Fang, Y., & Yang, L. (2024). Frontiers in CAR-T cell therapy for autoimmune diseases. Trends in Pharmacological Sciences, 45(9), 839–857. https://doi.org/10.1016/j.tips.2024.07.005
How many times has this paper been cited?
103 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Trends in Pharmacological Sciences: sign in and open the full text from this page.
Who wrote this paper?
Yan-Ruide Li, Zibai Lyu, Yuning Chen, Ying Fang, Lili Yang.
What is the DOI of this paper?
10.1016/j.tips.2024.07.005, permanently at https://doi.org/10.1016/j.tips.2024.07.005. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.